Acadia Pharmaceuticals Presents DAYBUE Real-World Evidence And Additional Data In Rett Syndrome At The 2024 IRSF Annual Scientific Meeting

Acadia Pharmaceuticals, Inc. (NASDAQ:ACAD) today announced that interim data from the open-label real-world LOTUS study will be presented at the 2024 International Rett Syndrome Foundation (IRSF) Annu

BenzingaJun 18 21:29

ACADIA Pharmaceuticals Holds Successful 2024 Annual Meeting

TipRanksMay 30 15:23

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February

U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected individuals about their personal and highly sensitive medical information stolen during a cyberattack ear

BenzingaMay 25 00:00

ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Will Probably Find It Hard To See A Huge Raise This Year

Key Insights ACADIA Pharmaceuticals to hold its Annual General Meeting on 29th of May CEO Steve Davis' total compensation includes salary of US$856.6k The overall pay is comparable to the industry

Simply Wall StMay 23 18:55

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that on May 15, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock

BusinesswireMay 18 04:05

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), ACADIA Pharmaceuticals (ACAD) and Disc Medicine (IRON)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on C4 Therapeutics (CCCC), ACADIA Pharmaceuticals (ACAD) and Disc Medicine (IRON).

TipRanksMay 13 10:10